Abstract
A National Institutes of Health proposal will restrict the licensing of Federally funded biomedical research tools for commercial gain.
MeSH terms
-
Biomedical Research*
-
Drug Industry
-
Federal Government
-
Financing, Government
-
Government Regulation*
-
Guidelines as Topic
-
Investments
-
National Institutes of Health (U.S.)
-
Patents as Topic / legislation & jurisprudence
-
Private Sector
-
Research Support as Topic*
-
United States